Urine Tricarboxylic Acid Cycle Metabolites and Risk of End-stage Kidney Disease in Patients With Type 2 Diabetes.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jian-Jun,Liu

第一单位： Clinical Research Unit, Khoo Teck Puat Hospital, Singapore 768828, Singapore.

作者： Jian-Jun,Liu ^[1] ; Sylvia,Liu ^[1] ; Huili,Zheng ^[1] ; Janus,Lee ^[1] ; Resham L,Gurung ^[1] ; Clara,Chan ^[1] ; Lye Siang,Lee ^[2] ; Keven,Ang ^[1] ; Jianhong,Ching ^[3] ; Jean-Paul,Kovalik ^[2] ; Subramaniam,Tavintharan ^[4] ; Chee Fang,Sum ^[4] ; Kumar,Sharma ^[5] ; Thomas M,Coffman ^[2] ; Su Chi,Lim ^[6]

作者单位： Clinical Research Unit, Khoo Teck Puat Hospital, Singapore 768828, Singapore. ^[1] Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore 169857, Singapore. ^[2] Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore 169857, Singapore.;KK Research Centre, KK Women's and Children's Hospital, Singapore 229899, Singapore. ^[3] Admiralty Medical Center, Khoo Teck Puat Hospital, Singapore 730676, Singapore. ^[4] Center for Precision Medicine, The University of Texas Health San Antonio, San Antonio, TX 78229, USA.;Division of Nephrology, Department of Medicine, The University of Texas Health San Antonio, San Antonio, TX 78229, USA. ^[5] Admiralty Medical Center, Khoo Teck Puat Hospital, Singapore 730676, Singapore.;Saw Swee Hock School of Public Heath, National University of Singapore, Singapore 117549, Singapore.;Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore. ^[6]

关键词 citrate end stage kidney disease fumarate tricarboxylic acid cycle type 2 diabetes urine metabolomics